language_icon
EN
HI

Akums Drugs & Pharmaceuticals Share price

AKUMS

516.95

10.95 (-2.07%)
NSE
BSE
Last updated on 15 May, 2026 | 15:56 IST
Today's High

532.30

Today's Low

500.05

52 Week Low

409.30

52 Week High

622.95

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Akums Drugs & Pharmaceuticals Chart

Akums Drugs & Pharmaceuticals Share Key Metrics

Volume
3.88 L
Market Cap
8136.48 CR
LTQ@LTP
1@516.95
ATP
517.32
Var Margin
17.38 %
Circuit Range
475.15-580.65
Delivery %
38.55 %
Value
20.06 CR
ASM/GSM
No
Market Lot
1

Summary

15 May, 2026 | 15:56 को, Akums Drugs & Pharmaceuticals का शेयर प्राइस आज ₹516.95 पर है, जो दिन के लिए 10.95% की -2.07 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹500.05 और ₹532.30 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹409.30 से ₹622.95 तक रही है। ट्रेडिंग गतिविधि के मामले में, Akums Drugs & Pharmaceuticals ने 387826 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹157393988 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹51732 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 1,51695 रही। यह स्टॉक ₹475.15-580.65 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹20.06 CR है। दिन के लिए डिलीवरी परसेंटेज 38.55% रही। इसके अतिरिक्त, Akums Drugs & Pharmaceuticals वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Akums Drugs & Pharmaceuticals Fundamentals

View More
P/E Ratio

32.47

P/B Ratio

2.58

Div. Yield

0

Sector P/E

67.24

Sector P/B

3.49

Sec. Div. Yield

0.56

Akums Drugs & Pharmaceuticals Resistance and Support

Pivot 532.52

Resistance

First Resistance

552.39

Second Resistance

576.87

Third Resistance

596.74

Support

First Support

508.04

Second Support

488.17

Third Support

463.69

Akums Drugs & Pharmaceuticals Shareholding Pattern

View More
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

75.26%

Mutual Fund

10.95%

Insurance

0.6%

Foreign Institutional Investors

1.38%

Domestic Institutional Investors

2.79%

Retail

9.02%

Others

0%

Total Promoters
MAR '26
75.26%

Akums Drugs & Pharmaceuticals Corporate Actions

DateAgenda
2026-05-14Audited Results & Final Dividend
2026-02-13Quarterly Results

Akums Drugs & Pharmaceuticals News

Akums Drugs and Pharmaceuticals Ltd - 544222 - Intimation Of Disruption In Operations At Some Of The Manufacturing Sites At Haridwar

Akums Drugs & Pharma reported temporary disruption of manufacturing operations at some Haridwar sites due to labour unrest on May 14, 2026. The company is actively working with authorities and workers to normalize operations.
May 14 2026 16:05:00

Akums Drugs and Pharmaceuticals Ltd - 544222 - Corporate Action-Board approves Dividend

Akums Drugs & Pharma recommended a total dividend of ₹3.00 per equity share for FY26, comprising a final dividend of ₹1.00 and a special dividend of ₹2.00. The record date is July 3, 2026.
May 14 2026 14:05:00

Akums Drugs and Pharmaceuticals Ltd - 544222 - Recommendation Of Final Cum Special Dividend

Akums Drugs & Pharma received show cause notices from the Income Tax Department for disallowance of expenses, stemming from a search and seizure operation in January 2025. This matter was noted by the auditor as an 'Emphasis of Matter', indicating potential unquantified financial impact.
May 14 2026 13:05:00

Akums Drugs and Pharmaceuticals Ltd - 544222 - Board Meeting Outcome for Outcome Of Board Meeting For Financial Results

Akums Drugs & Pharma Board approved FY26 consolidated financial results, reporting ₹4,487.74 crore revenue (up 7.6% YoY) and ₹256.40 crore net profit (down 25.4% YoY). A total dividend of ₹3.00 per share was recommended, with July 03, 2026, as the record date. The board also appointed new internal auditors and confirmed changes in senior HR management.
May 14 2026 13:05:00

Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Akums Drugs will conduct an analyst and investor conference call on May 18, 2026, to discuss its Q4 and full-year FY26 financial results. The virtual call will feature presentations from key management personnel, including the MDs, CFO, and Head Strategy.
May 12 2026 20:05:00

Akums Drugs and Pharmaceuticals Ltd - 544222 - Board Meeting Intimation for Board Meeting Intimation

Akums Drugs & Pharma's Board of Directors will convene on May 14, 2026, to consider and approve the audited financial results for Q4 FY26 and the full financial year. Additionally, the board will recommend a dividend, if any, for FY26.
May 11 2026 23:05:00

Akums Drugs and Pharmaceuticals Ltd - 544222 - Execution Of Lease Deed

Akums Drugs' wholly-owned subsidiary, Pure and Cure Healthcare, acquired an industrial plot of approximately 4050 Sq. Mtrs in Haridwar, Uttarakhand. This plot is adjacent to the existing manufacturing facility and will support the subsidiary's business operations.
Apr 29 2026 17:04:00
Read More

About Akums Drugs & Pharmaceuticals AboutThe

NSE : 24715  
BSE : 544222  
ISIN : INE09XN01023  

Our Company was incorporated as a public limited company under the Companies Act 1956 as ‘Akums Drugs and Pharmaceuticals Limited’ pursuant to a certificate of incorporation dated April 19 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13 2004.Major Events and Milestones:2004-Incorporation of the Company-Established first plant for oral dosage commissioned at 19 20 21 sector 6A Haridwar Uttarakhand2007-Established dedicated manufacturing site for oral liquid dosage at 22 Sector 6A Sidcul Haridwar Uttarakhand and sterile products at 2345 Sector 6B SIDCUL Haridwar Uttarakhand2009-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals2010-Dedicated a facility for hormones at 48 Sector 6A SIDCUL Haridwar Uttarakhand-Dedicated a facility for cosmetics and dermatology at 47 Sector 6A SIDCUL Haridwar Uttarakhand-Incorporated Akumentis Healthcare Limited to venture into branded formulations2011-Innovated bi-layered sustained release tablets for the first time2012-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities2013-Innovated tablet-in-tablet sustained release tablets for the first time-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities-Expanded into the African market2015-Expanded into the Asian market-Established research and development laboratory in Mumbai Maharashtra to venture into regulated market2016-Maxcure Nutravedics Limited received US-NSF certification2019-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder2021-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs-Acquisition of a facility at Kotdwar Uttarakhand by Akums Healthcare Limited2022-Plant at 19 20 21 Sector 6A SIDCUL Haridwar Uttarakhand and plant at 2 3 45 Sector 6B SIDCUL Haridwar Uttarakhand accredited European Union-Good Manufacturing Practices qualifying for exports to European markets-Acquisition of a facility in Haridwar Uttarakhand by Akums Healthcare Limited and a facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited2023-Acquisition of another facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

Read More

Akums Drugs & Pharmaceuticals Management

NamePosition
Sanjeev JainManaging Director
Sandeep JainManaging Director
View More

Akums Drugs & Pharmaceuticals FAQs

Akums Drugs & Pharmaceuticals शेयर का खरीद मूल्य 516.95 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Akums Drugs & Pharmaceuticals शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Akums Drugs & Pharmaceuticals शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 32.47 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Akums Drugs & Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.58 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Akums Drugs & Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.49 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Akums Drugs & Pharmaceuticals का मार्केट कैप 8136.48 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Akums Drugs & Pharmaceuticals शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 622.95 और 409.30 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost